End-of-day quote
16/09/2026
5-day change
1st Jan Change
86.00 NOK
-0.46%
-0.46%
-14.00%
Market Cap
51Cr
5.43Cr
4.74Cr
4.46Cr
4.07Cr
7.64Cr
519.04Cr
7.64Cr
54Cr
21Cr
265.06Cr
20Cr
20Cr
854.51Cr
P/E 2023 *
-
P/E 2024
3.26x Enterprise Value
26Cr
2.8Cr
2.44Cr
2.3Cr
2.1Cr
3.93Cr
267.38Cr
3.94Cr
28Cr
11Cr
136.54Cr
11Cr
10Cr
440.19Cr
EV / Sales 2023
-1.24x
EV / Sales 2024
0.4x Free-Float
6.26%
Yield 2023 *
-
Yield 2024
32.5%
Day Week Month
Close Mountain
17/06
Norda ASA announces Annual dividend, payable on June 25, 2026
CI
13/25/13
Norda ASA announces Annual dividend, payable on May 22, 2025
CI
06/25/06
Norda ASA Reports Earnings Results for the Full Year Ended December 31, 2024
CI
01/23/01
Norda ASA Reports Earnings Results for the Full Year Ended December 31, 2022
CI
16/22/16
Norda ASA Reports Earnings Results for the Full Year Ended December 31, 2021
CI
21/21/21
Norda Asa Reports Earnings Results for the Full Year Ended December 31, 2020
CI
22/13/22
Norda ASA Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2013
CI
09/13/09
Norda ASA Reports Unaudited Net Debt Results as of December 31, 2012
CI
09/13/09
Norda ASA Appoints Scient Frode Westvold as CEO
CI
28/13/28
Norda ASA Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended December 31, 2012
CI
31/12/31
Norda ASA Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2012
CI
12/12/12
Norda ASA Obtains NOK 35 Million Line of Credit from a Norwegian Bank
CI
29/12/29
Norda ASA Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2012
CI
1 day -0.46%
1 week -0.46%
Current month +1.18%
1 month -0.46%
3 months -0.46%
6 months +1.06%
Current year -14.00%
1 month
85
86.4
Current year
81
86.4
1 year
81
100
3 years
41
100
5 years
41
100
10 years
8
100
Manager
Title Age Since
Chief Executive Officer
-
08/04/2013
Director
Title Age Since
Chairman
54
31/01/2014
Director/Board Member
68
20/06/2013
Director/Board Member
-
-
2023 2024 Net sales
8.69Cr
91.96L
80.37L
75.54L
68.93L
1.29Cr
88Cr
1.29Cr
9.07Cr
3.5Cr
45Cr
3.45Cr
3.38Cr
144.74Cr
37Cr
3.93Cr
3.44Cr
3.23Cr
2.95Cr
5.53Cr
376.11Cr
5.54Cr
39Cr
15Cr
192.07Cr
15Cr
14Cr
619.19Cr
Net income
3.12Cr
32.98L
28.82L
27.09L
24.72L
46.4L
32Cr
46.4L
3.25Cr
1.25Cr
16Cr
1.24Cr
1.21Cr
52Cr
13Cr
1.33Cr
1.16Cr
1.09Cr
99.88L
1.87Cr
127.39Cr
1.87Cr
13Cr
5.07Cr
65Cr
5Cr
4.89Cr
209.72Cr
Net Debt
-31Cr
-3.29Cr
-2.88Cr
-2.7Cr
-2.47Cr
-4.63Cr
-314.8Cr
-4.63Cr
-32Cr
-13Cr
-160.76Cr
-12Cr
-12Cr
-518.27Cr
-25Cr
-2.63Cr
-2.3Cr
-2.16Cr
-1.97Cr
-3.7Cr
-251.66Cr
-3.7Cr
-26Cr
-10Cr
-128.52Cr
-9.89Cr
-9.67Cr
-414.32Cr
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Date
Price
Change
Volume
16/26/16
NOK 86.00
-0.46%
40
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-6pm CET
DAILY FREE LIMIT REACHED
To continue browsing, Sign up!
Personal watchlists and screeners
Access the "Discovery" Stock Screener (covering 30,000 companies)
Create your free account
Become a member and join over 1 million active investors
Already have an account?
Log in
Select your edition
All financial news and data tailored to specific country editions